HCFA/FDA Agreement On IDE Devices Needs "National Fix" - HCFA's Bagley
This article was originally published in The Gray Sheet
Executive Summary
Medicare coverage decisions for investigational devices should be made at the national rather than the carrier level, Health Care Financing Administration Office of Clinical Standards and Quality/Coverage and Analysis Group Director Grant Bagley said March 16.